Home › Funds › BANK OF MONTREAL /CAN/ › TEVA

BANK OF MONTREAL /CAN/ position in TEVA

TEVA PHARMACEUTICAL INDS LTD · Health Care

BANK OF MONTREAL /CAN/ reported holding 1,130,855 shares of TEVA (TEVA PHARMACEUTICAL INDS LTD) in its Q3 2026 13F filing — a position valued at US$4.53B, representing 5.54% of its reported portfolio and ranking #1 among its reported holdings. BANK OF MONTREAL /CAN/ has disclosed TEVA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.13M sh
Reported value held$4.53B
Portfolio Weight5.54%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How BANK OF MONTREAL /CAN/'s TEVA position evolved

BANK OF MONTREAL /CAN/ first disclosed a stake in TEVA in Q3 2023 at 356,684 shares (US$3.8M). The position peaked in Q3 2026 at 1,130,855 shares, worth US$4.53B. Across 13 filings, BANK OF MONTREAL /CAN/ increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 1,130,855 shares valued at US$4.53B — an increase of 159,272 shares quarter over quarter.. Notable position changes include a 75% increase in Q3 2025 (shares rose 55% over the following quarter), a 49% increase in Q4 2025 (shares fell 3% over the following quarter), a 29% trim in Q1 2026 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 356.68K $3.78M New
Q4 2023 356.72K $3.74M Hold
Q1 2024 354.11K $5.13M Reduce
Q2 2024 413.76K $6.83M Add
Q3 2024 408.01K $7.12M Reduce
Q4 2024 408.22K $9.00M Hold
Q1 2025 410.75K $6.31M Add
Q2 2025 475.94K $7.98M Add
Q3 2025 832.94K $16.83M Add
Q4 2025 1.24M $38.64M Add
Q1 2026 879.35K $26.49M Reduce
Q2 2026 971.58K $32.92M Add
Q3 2026 1.13M $4.53B Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TEVA and 13F data

TEVA (TEVA PHARMACEUTICAL INDS LTD) is a Health Care company. 46 other funds we track also report a position in TEVA — the largest reported positions include Phoenix Financial Ltd. (US$1.69B), WCM INVESTMENT MANAGEMENT, LLC (US$1.68B), Clal Insurance Enterprises Holdings Ltd (US$1.67B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TEVA

All TEVA fund holders →

FAQ

How long has BANK OF MONTREAL /CAN/ held TEVA?

BANK OF MONTREAL /CAN/ has disclosed TEVA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is BANK OF MONTREAL /CAN/'s current position in TEVA?

As of Q3 2026, BANK OF MONTREAL /CAN/ holds 1.13M shares of TEVA (TEVA PHARMACEUTICAL INDS LTD), valued at $4.53B, representing 5.54% of its reported portfolio and ranking #1.

Has BANK OF MONTREAL /CAN/ been buying or selling TEVA?

In the latest 13F filing (Q3 2026), BANK OF MONTREAL /CAN/ increased its position in TEVA. The position peaked in Q3 2026 at 1.13M shares.

Which other funds hold TEVA?

Other major institutional holders of TEVA include Phoenix Financial Ltd., WCM INVESTMENT MANAGEMENT, LLC, Clal Insurance Enterprises Holdings Ltd, among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.